ZNF200

Across TCGA pan-cancer cohorts, ZNF200 RNA is linked to patient survival in 27 of 34 cancer types, making it the most broadly survival-associated ZNF200 data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher ZNF200 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated ZNF200 expression acts as an unfavorable survival marker, although some lineages such as KIRC and SKCM show a favorable association.

ACC, KIRC, and LGG are the cancer types where ZNF200 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	DFS	Tertile	All	0.403	0.795	<.001	81	view →
KIRC	DFS	Median	All	0.888	0.703	<.001	57	view →
LGG	OS	Median	All	0.752	0.870	<.001	49	view →
SKCM	DFS	Tertile	All	0.697	0.511	.001	47	view →
SCLC	OS	Quartile	II,III,IV	0.690	0.244	.001	43	view →
COAD	DFS	Median	II,III,IV	0.711	0.403	.001	42	view →
UVM	DFS	Quartile	II,III,IV	0.320	0.837	.002	41	view →
READ	OS	Quartile	II,III,IV	1.000	0.307	.001	28	view →
LUSC	DFS	Tertile	III,IV	0.222	0.567	.002	27	view →
LIHC	DFS	Quartile	All	0.422	0.613	<.001	21	view →
KIRP	DFS	Quartile	III,IV	0.441	0.873	.009	15	view →
BRCA	OS	Tertile	IV	1.000	0.558	.011	13	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 27 lineages.

ZNF200–ACC (DFS)

Open the ACC breakdown →